XML 129 R108.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

Concentrations of Risk (Details) - manufacturer | 12 Months Ended
--- | ---
Mar. 31, 2024 | Mar. 31, 2023 | Mar. 31, 2022
Concentration Risk [Line Items] |  |  |
Number of third-party manufacturers | 122 |  |
Sales | Product concentration risk | Top 5 brands |  |  |
Concentration Risk [Line Items] |  |  |
Concentration risk, percentage | 37.90% | 38.70% | 41.30%
Sales | Customer concentration risk | Walmart |  |  |
Concentration Risk [Line Items] |  |  |
Concentration risk, percentage | 19.70% | 19.70% | 20.50%
Sales | Customer concentration risk | Amazon |  |  |
Concentration Risk [Line Items] |  |  |
Concentration risk, percentage | 10.90% |  |
Sales | Supplier concentration risk |  |  |
Concentration Risk [Line Items] |  |  |
Number of third-party manufacturers with long-term contracts | 26 | 25 |
Sales | Supplier concentration risk | Manufacturing Facility, Lynchburg, Virginia |  |  |
Concentration Risk [Line Items] |  |  |
Concentration risk, percentage | 11.00% |  |
Sales | Supplier concentration risk | Manufacturers |  |  |
Concentration Risk [Line Items] |  |  |
Concentration risk, percentage | 72.00% | 69.80% |
Sales | Supplier concentration risk | Contract Pharmacal Corporation |  |  |
Concentration Risk [Line Items] |  |  |
Concentration risk, percentage | 20.00% | 20.00% | 20.00%
Accounts receivable | Customer concentration risk | Walmart |  |  |
Concentration Risk [Line Items] |  |  |
Concentration risk, percentage | 19.20% |  |
Accounts receivable | Customer concentration risk | Amazon |  |  |
Concentration Risk [Line Items] |  |  |
Concentration risk, percentage | 11.00% |  |

X
- Definition Number of Third-party Manufacturers + References No definition available. + Details
Name: | pbh_NumberOfThirdPartyManufacturers
Namespace Prefix: | pbh_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of Third-party Manufacturers with Long-term Contracts + References No definition available. + Details
Name: | pbh_NumberOfThirdPartyManufacturersWithLongTermContracts
Namespace Prefix: | pbh_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 954 -SubTopic 310 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481027/954-310-50-2 + Details
Name: | us-gaap_ConcentrationRiskLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20 + Details
Name: | us-gaap_ConcentrationRiskPercentage1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=pbh_Top5BrandsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=pbh_WalmartMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=pbh_AmazonMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=pbh_ManufacturingFacilityLynchburgVirginiaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=pbh_ManufacturersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=pbh_ContractPharmacalCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |